title: Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
authors.forename: Bruno
authors.initials: B
authors.lastname: Pradines
authors.forename: Marylin
authors.initials: M
authors.lastname: Torrentino-Madamet
authors.forename: Albin
authors.initials: A
authors.lastname: Fontaine
authors.forename: Maud
authors.initials: M
authors.lastname: Henry
authors.forename: Eric
authors.initials: E
authors.lastname: Baret
authors.forename: Joel
authors.initials: J
authors.lastname: Mosnier
authors.forename: Sébastien
authors.initials: S
authors.lastname: Briolant
authors.forename: Thierry
authors.initials: T
authors.lastname: Fusai
authors.forename: Christophe
authors.initials: C
authors.lastname: Rogier
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D000069059:Atorvastatin; D004305:Dose-Response Relationship, Drug; D006538:Heptanoic Acids / Q000494:pharmacology*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D020128:Inhibitory Concentration 50; D016778:Malaria, Falciparum / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000235:genetics; D011758:Pyrroles / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D000962:Antimalarials; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin